| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/31/2023 | Seagen Inc. | SGEN | Grant | | 2k | $0.00 | $0 | | 05/31/2023 |
| 05/17/2023 | Travere Therapeutics, Inc. | RTRX | Grant | | 4.5k | $0.00 | $0 | | 05/17/2023 |
| 05/17/2023 | Travere Therapeutics, Inc. | RTRX | Grant | | 13.5k | $17.11 | $231k | | 05/17/2023 |
| 09/02/2022 | Atreca, Inc. | BCEL | Sale | Class A Common Stock | 20.9k | $1.78 | $37.1k | | 09/02/2022 |
| 06/13/2022 | Atreca, Inc. | BCEL | Disposition | Employee stock option (right to buy) | 148.8k | $10.02 | $1.5M | | 06/13/2022 |
| 06/13/2022 | Atreca, Inc. | BCEL | Grant | Employee stock option (right to buy) | 59k | $1.85 | $108.8k | | 06/13/2022 |
| 06/13/2022 | Atreca, Inc. | BCEL | Disposition | Employee stock option (right to buy) | 59k | $10.02 | $591.1k | | 06/13/2022 |
| 06/13/2022 | Atreca, Inc. | BCEL | Grant | Employee stock option (right to buy) | 260k | $1.85 | $479.7k | | 06/13/2022 |
| 06/13/2022 | Atreca, Inc. | BCEL | Disposition | Employee stock option (right to buy) | 260k | $13.97 | $3.6M | | 06/13/2022 |
| 06/13/2022 | Atreca, Inc. | BCEL | Grant | Employee stock option (right to buy) | 241k | $1.85 | $444.6k | | 06/13/2022 |
| 06/13/2022 | Atreca, Inc. | BCEL | Disposition | Employee stock option (right to buy) | 241k | $22.07 | $5.3M | | 06/13/2022 |
| 06/13/2022 | Atreca, Inc. | BCEL | Grant | Employee stock option (right to buy) | 148.8k | $1.85 | $274.5k | | 06/13/2022 |
| 05/13/2022 | Seagen Inc. | SGEN | Grant | Non-Qualified Stock Option (right to buy) | 3.7k | $135.63 | $498.6k | | 05/13/2022 |
| 05/13/2022 | Seagen Inc. | SGEN | Grant | Common Stock | 1.5k | $0.00 | $0 | | 05/13/2022 |
| 05/11/2022 | Travere Therapeutics, Inc. | RTRX | Grant | | 3k | $0.00 | $0 | | 05/11/2022 |
| 05/11/2022 | Travere Therapeutics, Inc. | RTRX | Grant | | 9k | $21.38 | $192.4k | | 05/11/2022 |
| 12/23/2021 | Atreca, Inc. | BCEL | Grant | Employee stock option (right to buy) | 260k | $3.18 | $826.8k | | 12/23/2021 |
| 09/09/2021 | Atreca, Inc. | BCEL | Grant | Class A Common Stock | 115.4k | $0.00 | $0 | | 09/09/2021 |
| 05/14/2021 | Travere Therapeutics, Inc. | RTRX | Grant | | 9k | $18.27 | $164.4k | | 05/14/2021 |
| 05/14/2021 | Travere Therapeutics, Inc. | RTRX | Grant | | 3k | $0.00 | $0 | | 05/14/2021 |
| 05/14/2021 | Seagen Inc. | SGEN | Grant | | 1.4k | $0.00 | $0 | | 05/14/2021 |
| 05/14/2021 | Seagen Inc. | SGEN | Grant | Non-Qualified Stock Option (right to buy) | 3.5k | $147.50 | $510.6k | | 05/14/2021 |
| 01/27/2021 | Atreca, Inc. | BCEL | Grant | Employee stock option (right to buy) | 260k | $13.97 | $3.6M | | 01/27/2021 |
| 05/15/2020 | Seagen Inc. | SGEN | Grant | | 1.3k | $0.00 | $0 | | 05/15/2020 |
| 05/15/2020 | Seagen Inc. | SGEN | Grant | Non-Qualified Stock Option (right to buy) | 3.2k | $160.33 | $508.4k | | 05/15/2020 |
| 05/15/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 3k | $0.00 | $0 | | 05/15/2020 |
| 05/15/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Employee stock option (right to buy) | 9k | $15.43 | $138.9k | | 05/15/2020 |
| 03/17/2020 | Atreca, Inc. | BCEL | Purchase | Class A Common Stock | 6k | $12.79 | $76.7k | | 03/17/2020 |
| 02/26/2020 | Atreca, Inc. | BCEL | Grant | Employee stock option (right to buy) | 241k | $22.07 | $5.3M | | 02/26/2020 |
| 07/30/2019 | ARRAY BIOPHARMA INC | ARRY | Disposition | Common Stock | 15k | $48.00 | $720k | | 07/30/2019 |
| 07/30/2019 | ARRAY BIOPHARMA INC | ARRY | Disposition | Stock Option (Right to Buy) | 25k | $3.87 | $96.8k | | 07/30/2019 |
| 07/30/2019 | ARRAY BIOPHARMA INC | ARRY | Disposition | Stock Option (Right to Buy) | 25k | $5.13 | $128.2k | | 07/30/2019 |
| 07/30/2019 | ARRAY BIOPHARMA INC | ARRY | Disposition | Stock Option (Right to Buy) | 25k | $5.95 | $148.8k | | 07/30/2019 |
| 07/30/2019 | ARRAY BIOPHARMA INC | ARRY | Disposition | Stock Option (Right to Buy) | 25k | $10.47 | $261.8k | | 07/30/2019 |
| 07/30/2019 | ARRAY BIOPHARMA INC | ARRY | Disposition | Stock Option (Right to Buy) | 25k | $14.55 | $363.8k | | 07/30/2019 |
|